Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 5
1970 6
1971 7
1972 3
1973 2
1974 7
1975 9
1976 6
1977 7
1978 8
1979 10
1980 19
1981 15
1982 12
1983 13
1984 31
1985 26
1986 27
1987 36
1988 26
1989 26
1990 21
1991 19
1992 22
1993 35
1994 40
1995 33
1996 46
1997 32
1998 34
1999 22
2000 32
2001 24
2002 28
2003 26
2004 12
2005 15
2006 16
2007 27
2008 22
2009 15
2010 15
2011 14
2012 13
2013 15
2014 4
2015 4
2016 1
2017 6
2018 7
2019 2
2020 4
2021 8
2022 6
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

895 results

Results by year

Filters applied: . Clear all
Page 1
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.
Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, Cervantes F, Clark RE, Cortes JE, Guilhot F, Hjorth-Hansen H, Hughes TP, Kantarjian HM, Kim DW, Larson RA, Lipton JH, Mahon FX, Martinelli G, Mayer J, Müller MC, Niederwieser D, Pane F, Radich JP, Rousselot P, Saglio G, Saußele S, Schiffer C, Silver R, Simonsson B, Steegmann JL, Goldman JM, Hehlmann R. Baccarani M, et al. Among authors: goldman jm. Blood. 2013 Aug 8;122(6):872-84. doi: 10.1182/blood-2013-05-501569. Epub 2013 Jun 26. Blood. 2013. PMID: 23803709 Free PMC article. Review.
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.
Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R, Chuah C, Nicolini FE, Apperley JF, Khoury HJ, Talpaz M, DiPersio J, DeAngelo DJ, Abruzzese E, Rea D, Baccarani M, Müller MC, Gambacorti-Passerini C, Wong S, Lustgarten S, Rivera VM, Clackson T, Turner CD, Haluska FG, Guilhot F, Deininger MW, Hochhaus A, Hughes T, Goldman JM, Shah NP, Kantarjian H; PACE Investigators. Cortes JE, et al. Among authors: goldman jm. N Engl J Med. 2013 Nov 7;369(19):1783-96. doi: 10.1056/NEJMoa1306494. Epub 2013 Nov 1. N Engl J Med. 2013. PMID: 24180494 Free PMC article. Clinical Trial.
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fischer T, Hochhaus A, Hughes T, Lechner K, Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ; IRIS Investigators. O'Brien SG, et al. Among authors: goldman jm. N Engl J Med. 2003 Mar 13;348(11):994-1004. doi: 10.1056/NEJMoa022457. N Engl J Med. 2003. PMID: 12637609 Free article. Clinical Trial.
Chronic myeloid leukemia.
Deininger MW, Goldman JM. Deininger MW, et al. Among authors: goldman jm. Curr Opin Hematol. 1998 Jul;5(4):302-8. doi: 10.1097/00062752-199807000-00010. Curr Opin Hematol. 1998. PMID: 9747637 Review.
Chronic myelogenous leukemia.
Druker BJ, Sawyers CL, Capdeville R, Ford JM, Baccarani M, Goldman JM. Druker BJ, et al. Among authors: goldman jm. Hematology Am Soc Hematol Educ Program. 2001:87-112. doi: 10.1182/asheducation-2001.1.87. Hematology Am Soc Hematol Educ Program. 2001. PMID: 11722980 Review.
Ponatinib for chronic myeloid leukemia.
Goldman JM. Goldman JM. N Engl J Med. 2012 Nov 29;367(22):2148-9. doi: 10.1056/NEJMe1210796. N Engl J Med. 2012. PMID: 23190226 No abstract available.
Treatment strategies for CML.
Goldman JM. Goldman JM. Best Pract Res Clin Haematol. 2009 Sep;22(3):303-13. doi: 10.1016/j.beha.2009.08.001. Best Pract Res Clin Haematol. 2009. PMID: 19959082 Review.
The Launch of the iCoDE Standard Project.
Xu NY, Nguyen KT, DuBord AY, Klonoff DC, Goldman JM, Shah SN, Spanakis EK, Madlock-Brown C, Sarlati S, Rafiq A, Wirth A, Kerr D, Khanna R, Weinstein S, Espinoza J. Xu NY, et al. Among authors: goldman jm. J Diabetes Sci Technol. 2022 Jul;16(4):887-895. doi: 10.1177/19322968221093662. Epub 2022 May 9. J Diabetes Sci Technol. 2022. PMID: 35533135 Free PMC article.
Current pre-clinical and clinical advances in the BCR-ABL1-positive and -negative chronic myeloproliferative neoplasms.
Mughal TI, Vannucchi AM, Soverini S, Bazeos A, Tibes R, Saglio G, Abdel-Wahab O, Pardanani A, Hehlmann R, Barbui T, Van Etten R, Tefferi A, Goldman JM. Mughal TI, et al. Among authors: goldman jm. Haematologica. 2014 May;99(5):797-801. doi: 10.3324/haematol.2013.097832. Haematologica. 2014. PMID: 24790057 Free PMC article. Review. No abstract available.
Chronic myeloid leukemia.
Goldman JM. Goldman JM. Curr Opin Hematol. 1997 Jul;4(4):277-85. doi: 10.1097/00062752-199704040-00009. Curr Opin Hematol. 1997. PMID: 9260056 Review.
895 results